Literature DB >> 954222

The effect of varying doses of cerebral irradiation on growth hormone production in childhood.

S M Shalet, C G Beardwell, D Pearson, P H Jones.   

Abstract

The radiation dose, delivered to the hypothalamic-pituitary region, has been calculated in thirty-nine children irradiated for brain tumours and in seventeen children who had received prophylactic cranial irradiation for acute leukaemia. All subjects had an insulin tolerance test at least 2 years after their radiotherapy. There is a significant inverse correlation between radiation dose and peak GH response. Thirty-seven of the fifty-six patients showed an impaired GH response and thirty-six of these received more than 2900 rads. Only five patients who received such a dose showed normal GH responses and four of these were aged over 13 years when treated. In conclusion, cerebral irradiation is a potent cause of GH deficiency in children.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 954222     DOI: 10.1111/j.1365-2265.1976.tb01955.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  30 in total

Review 1.  Toward a cure for infants with brain tumours: the challenge for the 1990's.

Authors:  P M Zeltzer
Journal:  Br J Cancer Suppl       Date:  1992-08

2.  Moderate dose cranial radiotherapy causes central adrenal insufficiency in long-term survivors of childhood leukaemia.

Authors:  C Follin; T Wiebe; C Moëll; E M Erfurth
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

Review 3.  Growth hormone - past, present and future.

Authors:  Michael B Ranke; Jan M Wit
Journal:  Nat Rev Endocrinol       Date:  2018-03-16       Impact factor: 43.330

4.  Medulloblastoma in childhood. Survival and functional results.

Authors:  J F Hirsch; D Renier; P Czernichow; L Benveniste; A Pierre-Kahn
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

5.  Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours.

Authors:  E A Livesey; C G Brook
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

6.  Growth following single fraction and fractionated total body irradiation for bone marrow transplantation.

Authors:  B C Thomas; R Stanhope; P N Plowman; A D Leiper
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

7.  Growth response to growth hormone therapy following cranial irradiation.

Authors:  P E Clayton; S M Shalet; D A Price
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

Review 8.  Hypopituitarism following radiotherapy.

Authors:  Ken H Darzy; Stephen M Shalet
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

9.  Growth and endocrine function after treatment for medulloblastoma.

Authors:  I H Brown; T J Lee; O B Eden; J A Bullimore; D C Savage
Journal:  Arch Dis Child       Date:  1983-09       Impact factor: 3.791

10.  Growth and growth hormone in children during and after therapy for acute lymphoblastic leukaemia.

Authors:  M Caruso-Nicoletti; M Mancuso; G Spadaro; S P Dibenedetto; A DiCataldo; G Schiliró
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.